IRF1 and pancreatic neoplasm: Taken together, we discovered that down-regulation of CTD-3252C9.4 facilitates pancreatic cancer progression via unbinding IRF1 to amplify IFI6 expression, hindering cell apoptosis and facilitating cell proliferation.